Jun 24, 2026
Natera (NTRA) Stock Soars 7% Following Japanese Regulatory Milestone for Signatera
Natera (NTRA) stock rose 7.67% after Japan approved Signatera for colorectal cancer MRD testing, marking the country's first authorized test of its kind.
The post Natera (NTRA) Stock Soars 7% Following Japanese Regulatory Milestone for Signatera appeared first on Blockonomi.
Source: Blockonomi →Related News
- 37 minutes ago
SpaceX (SPCX) Stock Plunges Below IPO Price After Starship Engine Failure
- 44 minutes ago
Tesla (TSLA) Earnings Preview: 7% Swing Expected as Wall Street Eyes Robotaxi Up...
- 45 minutes ago
Is Cerebras Systems (CBRS) Stock a Buy Following Its IPO Pullback?
- 53 minutes ago
Apple (AAPL) Reclaims Crown as World’s Most Valuable Company, Surpassing Nvidia...
- 54 minutes ago
Alphabet (GOOGL) Stock Slides 4% Following Gemini AI Setback Despite Record Earn...